ÂÜÀòÂÒÂ×

Tine Bekaert is a seasoned investment manager in the life sciences and healthcare sectors, currently serving as a Senior Investment Manager at PMV - Doe- en Durfbedrijf since June 2020, overseeing the entire investment process from deal sourcing to closing. In addition to this role, Tine acts as a board member for several healthcare companies, including Flamingo Therapeutics, Dualyx, Nobi, and Indigo Diabetes. Previous experience includes a senior management position at Deloitte Belgium, where Tine supported global companies in R&D investments and sustainability projects, and served as a grants specialist focusing on EU and local funding. Tine's career began as a policy advisor for the Vlaamse Overheid, where responsibilities included managing Flemish participation in European research initiatives. Academic qualifications include a PhD in Biotechnology and a Master's degree from Ghent University, alongside a recent executive education from Vlerick Business School.